Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response
Liang Xie, … , Junmin Peng, Cam Patterson
Liang Xie, … , Junmin Peng, Cam Patterson
Published July 17, 2012
Citation Information: J Clin Invest. 2012;122(8):2827-2836. https://doi.org/10.1172/JCI62374.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 1

PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response

  • Text
  • PDF
Abstract

The DNA damage response (DDR) is a complex regulatory network that is critical for maintaining genome integrity. Posttranslational modifications are widely used to ensure strict spatiotemporal control of signal flow, but how the DDR responds to environmental cues, such as changes in ambient oxygen tension, remains poorly understood. We found that an essential component of the ATR/CHK1 signaling pathway, the human homolog of the Caenorhabditis elegans biological clock protein CLK-2 (HCLK2), associated with and was hydroxylated by prolyl hydroxylase domain protein 3 (PHD3). HCLK2 hydroxylation was necessary for its interaction with ATR and the subsequent activation of ATR/CHK1/p53. Inhibiting PHD3, either with the pan-hydroxylase inhibitor dimethyloxaloylglycine (DMOG) or through hypoxia, prevented activation of the ATR/CHK1/p53 pathway and decreased apoptosis induced by DNA damage. Consistent with these observations, we found that mice lacking PHD3 were resistant to the effects of ionizing radiation and had decreased thymic apoptosis, a biomarker of genomic integrity. Our identification of HCLK2 as a substrate of PHD3 reveals the mechanism through which hypoxia inhibits the DDR, suggesting hydroxylation of HCLK2 is a potential therapeutic target for regulating the ATR/CHK1/p53 pathway.

Authors

Liang Xie, Xinchun Pi, Ashutosh Mishra, Guohua Fong, Junmin Peng, Cam Patterson

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Total
Citations: 2 5 4 2 3 4 3 4 2 8 4 4 45
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (45)

Title and authors Publication Year
PHD1-3 oxygen sensors in vivo-lessons learned from gene deletions.
Jucht AE, Scholz CC
2024
Endothelial EGLN3-PKM2 signaling induces the formation of acute astrocytic barrier to alleviate immune cell infiltration after subarachnoid hemorrhage
Duan M, Ru X, Zhou J, Li Y, Guo P, Kang W, Li W, Chen Z, Feng H, Chen Y
Fluids and barriers of the CNS 2024
Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance
Carney SV, Banerjee K, Mujeeb A, Zhu B, Haase S, Varela ML, Kadiyala P, Tronrud CE, Zhu Z, Mukherji D, Gorla P, Sun Y, Tagett R, Núñez FJ, Luo M, Luo W, Ljungman M, Liu Y, Xia Z, Schwendeman A, Qin T, Sartor MA, Costello JF, Cahill DP, Lowenstein PR, Castro MG
Clinical cancer research 2023
PHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway: PHD3 inhibits metastasis via occludin-p38 MAPK
Li Y, Yuan T, Zhang H, Liu S, Lun J, Guo J, Wang Y, Zhang Y, Fang J
Acta Biochimica et Biophysica Sinica 2023
Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke.
Xie J, Zhang Z
Molecular Neurobiology 2023
Oxygen‐regulated post‐translation modifications as master signalling pathway in cells
Batie M, Fasanya T, Kenneth NS, Rocha S
EMBO reports 2023
Integrated systems biology approach identifies gene targets for endothelial dysfunction
Pinheiro\u2010de\u2010Sousa I, Fonseca\u2010Alaniz MH, Giudice G, Valadão IC, Modestia SM, Mattioli SV, Junior RR, Zalmas L, Fang Y, Petsalaki E, Krieger JE
Molecular Systems Biology 2023
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth
Y Jin, Y Pan, S Zheng, Y Liu, J Xu, Y Peng, Z Zhang, Y Wang, Y Xiong, L Xu, K Mu, S Chen, F Zheng, Y Yuan, J Fu
Oncogene 2022
Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity
J Li, C Chen, C Li, Z Hu, J Tan, L Zeng
Frontiers in Cell and Developmental Biology 2022
Endothelial Transient Receptor Potential Canonical Channel Regulates Angiogenesis and Promotes Recovery After Myocardial Infarction
X Wen, Y Peng, M Gao, Y Zhu, Y Zhu, F Yu, T Zhou, J Shao, L Feng, X Ma
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2022
PHD3 inhibits cell proliferation through hydroxylation of PAX2 at proline 9: PHD3 hydroxylates PAX2
Lun J, Wang Y, Gao Q, Wang Y, Zhang H, Fang J
Acta Biochimica et Biophysica Sinica 2022
Role of Hypoxia in the Control of the Cell Cycle
J Druker, JW Wilson, F Child, D Shakir, T Fasanya, S Rocha
International journal of molecular sciences 2021
Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins
SJ Wong, AE Ringel, W Yuan, JA Paulo, H Yoon, MA Currie, MC Haigis
The Journal of biological chemistry 2021
Prolyl hydroxylase 3 controls the intestine goblet cell generation through stabilizing ATOH1
Y Xu, Q Gao, J Zhang, Y Lu, D Xing, Y Qin, J Fang
Cell Death and Differentiation 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
A Reustle, MD Marco, C Meyerhoff, A Nelde, JS Walz, S Winter, S Kandabarau, F Büttner, M Haag, L Backert, DJ Kowalewski, S Rausch, J Hennenlotter, V Stühler, M Scharpf, F Fend, A Stenzl, HG Rammensee, J Bedke, S Stevanović, M Schwab, E Schaeffeler
Genome Medicine 2020
NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial–Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production
WN Xu, RZ Yang, HL Zheng, LS Jiang, SD Jiang
Frontiers in Cell and Developmental Biology 2020
Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress: NDUFA4L2 promotes LC cell vitality
L Meng, X Yang, X Xie, M Wang
Thoracic Cancer 2019
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53–MDM2 interaction in a hydroxylase-independent manner
Y Xu, Q Gao, Y Xue, X Li, L Xu, C Li, Y Qin, J Fang
The Journal of biological chemistry 2019
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
S Li, J Rodriguez, W Li, P Bullova, SM Fell, O Surova, I Westerlund, D Topcic, M Bergsland, A Stenman, J Muhr, M Nistér, J Holmberg, CC Juhlin, C Larsson, A von Kriegsheim, WG Kaelin, S Schlisio
Proceedings of the National Academy of Sciences 2019
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
ME Cockman, K Lippl, YM Tian, HB Pegg, WD Jnr, MI Abboud, R Heilig, R Fischer, J Myllyharju, CJ Schofield, PJ Ratcliffe
eLife 2019
Prolyl hydroxylase domain-2 protein regulates lipopolysaccharide-induced vascular inflammation
Q Fan, H Mao, L Xie, X Pi
The American Journal of Pathology 2018
Hypoxic Signalling in Tumour Stroma
A Laitala, JT Erler
Frontiers in Oncology 2018
PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
J Rodriguez, A Herrero, S Li, N Rauch, A Quintanilla, K Wynne, A Krstic, JC Acosta, C Taylor, S Schlisio, A von Kriegsheim
Cell Reports 2018
Simvastatin ameliorates ionizing radiation-induced apoptosis in the thymus by activating the AKT/sirtuin 1 pathway in mice
H Yang, F Huang, Y Tao, X Zhao, L Liao, X Tao
International journal of molecular medicine 2017
Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair
SK Ghadge, M Messner, TV Pham, M Doppelhammer, A Petry, A Görlach, B Husse, WM Franz, MM Zaruba
Journal of Molecular Medicine 2017
PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis
ZR Schoepflin, ES Silagi, IM Shapiro, MV Risbud
The FASEB Journal 2017
PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
RF Koncar, Z Chu, LE Romick-Rosendale, SI Wells, TA Chan, X Qi, EM Bahassi
Oncotarget 2017
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes
A Stoehr, Y Yang, S Patel, AM Evangelista, A Aponte, G Wang, P Liu, J Boylston, PH Kloner, Y Lin, M Gucek, J Zhu, E Murphy
Cardiovascular Research 2016
Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways
J Rodriguez, R Pilkington, A Garcia Munoz, LK Nguyen, N Rauch, S Kennedy, N Monsefi, A Herrero, CT Taylor, A von Kriegsheim
Cell Reports 2016
PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban
Liang Xie, Xinchun Pi, W.H. Davin Townley-Tilson, Li Na, Xander H.T. Wehrens, Mark L. Entman, George E. Taffet, Ashutosh Mishra, Junmin Peng, Jonathan Schisler, Gerhard Meissner, Cam Patterson
Journal of Clinical Investigation 2015
PHD1 regulates p53-mediated colorectal cancer chemoresistance
S Deschoemaeker, GD Conza, S Lilla, R Martin-Perez, D Mennerich, L Boon, S Hendrikx, OD Maddocks, C Marx, P Radhakrishnan, H Prenen, M Schneider, J Myllyharju, T Kietzmann, KH Vousden, S Zanivan, M Mazzone
EMBO Molecular Medicine 2015
The role of hypoxia in inflammatory disease (Review)
J Biddlestone, D Bandarra, S Rocha
International journal of molecular medicine 2015
PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function
Y Chen, HS Zhang, GH Fong, QL Xi, GH Wu, CG Bai, ZQ Ling, L Fan, YM Xu, YQ Qin, TL Yuan, H Sun, J Fang
The Journal of biological chemistry 2015
Depletion of PHD3 Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis
L Xie, X Pi, Z Wang, J He, MS Willis, C Patterson
Journal of Molecular and Cellular Cardiology 2015
Identification of prolyl hydroxylation modifications in mammalian cell proteins
PR Arsenault, KJ Heaton-Johnson, L Li, D Song, VS Ferreira, N Patel, SR Master, FS Lee
PROTEOMICS 2015
Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
S Kim, E Yang
Molecules (Basel, Switzerland) 2015
CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells
B Ortmann, D Bensaddek, S Carvalhal, SC Moser, S Mudie, ER Griffis, JR Swedlow, AI Lamond, S Rocha
Journal of cell science 2015
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
P Pollard, M Yang, H Su, T Soga, K Kranc
Hypoxia 2014
Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions
L Swain, M Wottawa, A Hillemann, A Beneke, H Odagiri, K Terada, M Endo, Y Oike, K Farhat, DM Katschinski
Journal of leukocyte biology 2014
Cell cycle progression in response to oxygen levels
B Ortmann, J Druker, S Rocha
Cellular and Molecular Life Sciences 2014
PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility
W Luo, B Lin, Y Wang, J Zhong, R O'Meally, RN Cole, A Pandey, A Levchenko, GL Semenza
Molecular biology of the cell 2014
Prolyl-hydroxylase 3: Evolving Roles for an Ancient Signaling Protein
TL Place, FE Domann
2013
PHD1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192
SC Moser, D Bensaddek, B Ortmann, JF Maure, S Mudie, JJ Blow, AI Lamond, JR Swedlow, S Rocha
Developmental Cell 2013
Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition
TL Place, JT Nauseef, MK Peterson, MD Henry, JJ Mezhir, FE Domann
PloS one 2013
Centrosomes tune in to metabolic state and turn on to oxygen
SK and, BD Dynlacht
Developmental Cell 2013

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
55 readers on Mendeley
See more details